Écrit par WHO | 17 Janvier 2015

On Tuesday 20 January 2015, the World Health Organisation (WHO) will convene the Emergency Committee (EC) on Ebola under the International Health Regulations (IHR) (2005) for the fourth time.

The objectives of this fourth meeting include a review of the situation and the response to Ebola in West Africa. The participants will also advise on whether adjustments should be made to the...

Écrit par ANSM | 17 Janvier 2015

Lors de sa réunion mensuelle qui s’est tenue du 5 au 9 janvier 2015 à Londres, le Comité pour l’Evaluation des Risques en matière de Pharmacovigilance (PRAC) de l’Agence européenne des médicaments (EMA) a finalisé la réévaluation du rapport bénéfice/risque des médicaments à base d’ambroxol ou de bromhexine. Il a, par ailleurs, pris en compte un signal de sécurité...

Écrit par BONE THERAPEUTICS | 17 Janvier 2015

Gosselies, Belgium, 16 January 2015 - BONE THERAPEUTICS, the bone cell therapy company addressing high unmet medical needs in the field of bone fracture repair and bone fracture prevention, announces today its intention to raise new funds through an Initial Public Offering on Euronext Brussels and Euronext Paris.

HighlightsBone Therapeutics is a leader in bone cell therapySince it was...

Écrit par WHO | 17 Janvier 2015

Geneva- One year after the first Ebola cases started to surface in Guinea, WHO is publishing this series of 14 papers that take an in-depth look at West Africa’s first epidemic of Ebola virus disease.

The papers explore reasons why the disease evaded detection for several months and the factors, many specific to West Africa, that fuelled its subsequent spread.

The most extensive papers...